These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1721448)
1. Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survival. Davies CB; Cofer BR; Alexander JW Transplant Proc; 1991 Dec; 23(6):3314-5. PubMed ID: 1721448 [No Abstract] [Full Text] [Related]
2. FK 506 enhances the beneficial effects of donor-specific blood transfusion on allograft survival in rats. Fabrega AJ; Blanchard JM; Braucher E; Dumble L; Rivas P; Pollak R Transplant Proc; 1991 Dec; 23(6):3312-3. PubMed ID: 1721447 [No Abstract] [Full Text] [Related]
3. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival. Fisher RA; Cohen DS; Alexander JW; Davies CB; Schroeder TJ Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961 [No Abstract] [Full Text] [Related]
4. Prolonged cardiac allograft survival in sensitized rats by low-dose FK 506 in combination with splenectomy. Jiang H; Takahara S; Kyo M; Hashimoto M; Takano Y; Kameoka H; Moutabarrik A; Kokado Y; Ishibashi M; Okuyama A Transplant Proc; 1991 Dec; 23(6):3291-2. PubMed ID: 1721439 [No Abstract] [Full Text] [Related]
5. Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine. Jiang H; Takahara S; Takano Y; Li D; Kyo M; Valdivia LA; Kokado Y; Ishibashi M; Sonoda T Transplant Proc; 1991 Feb; 23(1 Pt 1):540-1. PubMed ID: 1703702 [No Abstract] [Full Text] [Related]
6. Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. Kuroki H; Bean MA; Ikuta Y; Burgess EM Transplant Proc; 1991 Dec; 23(6):3282-4. PubMed ID: 1721436 [No Abstract] [Full Text] [Related]
7. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine. Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904 [No Abstract] [Full Text] [Related]
8. Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative period. Cofer BR; Tchervenkov JI; Alexander JW; Barnwell SC Transplant Proc; 1991 Feb; 23(1 Pt 1):157-8. PubMed ID: 1990501 [No Abstract] [Full Text] [Related]
9. Effect of ultraviolet-B-irradiated donor-specific blood transfusion and cyclosporine on cardiac allograft survival and mixed lymphocyte reaction in rats. Koh YB; Park IY; Lee YK Transplant Proc; 1994 Aug; 26(4):1952-3. PubMed ID: 8066632 [No Abstract] [Full Text] [Related]
10. Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine. Jiang H; Fujitsu T; Sakuma S; Ogawa T; Tamura K; Fujii Y; Akiyama Y; Izumi S; Takahara S; Ishibashi M Transplant Proc; 1995 Feb; 27(1):367-9. PubMed ID: 7533413 [No Abstract] [Full Text] [Related]
11. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959 [No Abstract] [Full Text] [Related]
12. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage. Tchervenkov JI; Cofer BR; Davies C; Alexander JW Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476 [No Abstract] [Full Text] [Related]
14. A new rat infection-heart transplant model: effect of infection on graft survival studies. Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253 [TBL] [Abstract][Full Text] [Related]
15. Survival of cardiac allograft in highly sensitized and nonsensitized rats treated with FK506. Takahara S; Jiang H; Ishibashi M; Okuyama A; Sonoda T J Clin Lab Immunol; 1991 Apr; 34(4):179-81. PubMed ID: 1726566 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of UV-irradiated donor-specific transfusions with peritransplant cyclosporine on cardiac allograft survival in rats. Oluwole S; Lau H; Reemtsma K; Hardy MA Transplant Proc; 1987 Feb; 19(1 Pt 1):451-3. PubMed ID: 3274803 [No Abstract] [Full Text] [Related]
17. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts. Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575 [TBL] [Abstract][Full Text] [Related]
18. Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness. Langrehr JM; Hoffman RA; Müller AR; Lee KK; Demetris AJ; Schraut WH Transplant Proc; 1991 Dec; 23(6):3248-50. PubMed ID: 1721425 [No Abstract] [Full Text] [Related]
19. Combination therapy with FK 506 and splenectomy may induce tolerance in cardiac xenografts. Nishimori H; Suzuki S; Kido K; Tashiro H; Arita S; Ohdan H; Amemiya H Transplant Proc; 1994 Jun; 26(3):1064-6. PubMed ID: 7518102 [No Abstract] [Full Text] [Related]